Apparatus, systems and methods for transvascular access to the brain
The present disclosure discusses a devices, systems and methods for transvascular, transvenous and/or transdural access, to the brain parenchyma, subarachnoid or subdural spaces. In some embodiments, the disclosed systems and methods may be used for local drug delivery, tissue biopsy, nanofluidic or microelectronic device/component delivery/insertion/implantation, in situ imaging, ablation of abnormal brain tissue and the like. Embodiments of the present disclosure include an access catheter system for extravascular procedures in the brain having an elongate, flexible tubular body, with at least one lumen extending axially there through between a proximal end, and a distal end. The access catheter system may include a side exit port and a distal end port. Further, the access catheter system may include a selective deflector positioned within the lumen configured to deflect a procedure catheter and permit a guide catheter.
1. A method of providing transvascular access to an extravascular site, the method comprising the steps of:
advancing an access catheter over a guide to position a side exit port of the access catheter adjacent to a target site of a vessel;
retracting the guide from the access catheter;
advancing a procedure catheter through the access catheter and to the target site of the vessel via the side exit port of the access catheter, wherein a selective deflector in the access catheter deflects the procedure catheter out through the side exit port, but permits the guide to advance distally beyond the deflector and out of a distal end of the access catheter;
deploying the procedure catheter through the side exit port;
advancing a second device through a vein wall at the target site, thereby creating a venous puncture site;
advancing a wire through the second device at the venous puncture site to deploy a second procedure catheter with advanced functionality;
removing the second device;
deploying supporting expandable structural elements of the access catheter;
repositioning the access catheter such that at least a balloon of the access catheter overlays the venous puncture site; and
inflating the balloon of the access catheter such that it contacts the venous puncture site, thereby tamponading the venous puncture site to produce hemostasis.
2. The method of claim 1 , further comprising:
evaluating if hemostasis has been achieved by deflating the balloon of the access catheter; and
deploying an implantable biosynthetic, bioabsorbable hemostatic material from the side exit port responsive to determining that hemostasis from balloon tamponade not being achieved.
3. The method of claim 2 , wherein the biosynthetic, bioabsorbable hemostatic material further comprises at least one of Poly (L) polymer, and Dextran-Sucrose-Sodium Citrate polymer.